There was a trend of reduction in HCC in treated patients, but it did not reach statistical significance in those co-existing with all three HCC-associated SNVs because of the limited number of cases (Supplementary Fig. 5).
← all excerpts
The impact of single-nucleotide variants of hepatitis B virus and antiviral on liver cancer in gray zone patients.
1
—
—